Australia Determined To Vaccinate By Release Of Aerosolized GMO Vaccine
The Office of the Gene Technology Regulator (OGTR) is on its way to
approve a licence application from PaxVax Australia (PaxVax) for the
intentional release of a GMO vaccine consisting of live bacteria into
the environment in Queensland, South Australia, Western Australia and
Victoria.
According to the regulator, it qualifies as a limited and controlled release under section 50A of the Gene Technology Act 2000 (the Act).
PaxVax is seeking approval to conduct the clinical trial of a
genetically modified live bacterial vaccine against cholera. Once
underway the trial is expected to be completed within one year, with
trial sites selected from local government areas (LGAs) in Queensland,
South Australia, Victoria and Western Australia.
PaxVax has
proposed a number of control measures they say will restrict the spread
and persistence of the GM vaccine and its introduced genetic material,
however there is always a possiblity of these restrictions failing and
infecting wildlife and ecosystems.
Aerial vaccines have used in
the United States directed towards animals by the use of plastic packets
dropped by planes or helicopters. Sanofi (who is one of the largest vaccine manufacturers in the world) has subsidiary companies such as Merial Limited who manufacture Raboral, an oral live-virus poisonous to humans yet distributed wildlife in the masses.
No comments:
Post a Comment